Morningstar

Eurofins Medical Device Services Launches first GMP PFAS Screening and Testing Solutions for Medical Devices

Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launcheda GMPPFAS ...

STEMart Announces Enhanced In Vivo Rat Micronucleus Test Services to Accelerate Medical Device Biocompatibility Testing

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
Morningstar

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
MD&M East

Cytotoxicity Testing for Medical Devices: A Guide to Compliance & Best Practices

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...